Farid Kianifard

5.1k total citations · 1 hit paper
91 papers, 3.8k citations indexed

About

Farid Kianifard is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Statistics and Probability. According to data from OpenAlex, Farid Kianifard has authored 91 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Physiology, 21 papers in Pulmonary and Respiratory Medicine and 18 papers in Statistics and Probability. Recurrent topics in Farid Kianifard's work include Asthma and respiratory diseases (31 papers), Allergic Rhinitis and Sensitization (16 papers) and Respiratory and Cough-Related Research (10 papers). Farid Kianifard is often cited by papers focused on Asthma and respiratory diseases (31 papers), Allergic Rhinitis and Sensitization (16 papers) and Respiratory and Cough-Related Research (10 papers). Farid Kianifard collaborates with scholars based in United States, Switzerland and France. Farid Kianifard's co-authors include David G. Kleinbaum, J. D. Jobson, William H. Swallow, Marc Massanari, William W. Busse, Gregory P. Geba, Robert K. Zeldin, Benjamin Ortiz, Paul Gallo and Harold S. Nelson and has published in prestigious journals such as Journal of the American Statistical Association, Technometrics and PEDIATRICS.

In The Last Decade

Farid Kianifard

88 papers receiving 3.6k citations

Hit Papers

Applied Linear Regression Models 1990 2026 2002 2014 1990 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Applied Linear Regression Models
    1990 1.1k citations Farid Kianifard et al. Technometrics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Farid Kianifard United States 28 730 483 413 273 253 91 3.8k
Roger D. Peng United States 57 1.1k 1.6× 715 1.5× 587 1.4× 349 1.3× 193 0.8× 182 13.4k
Werner Vach Germany 52 582 0.8× 1.0k 2.2× 144 0.3× 359 1.3× 765 3.0× 397 9.3k
Virginia A. Clark United States 48 474 0.6× 616 1.3× 231 0.6× 513 1.9× 436 1.7× 133 8.4k
Alan B. Forsythe United States 36 777 1.1× 551 1.1× 299 0.7× 670 2.5× 554 2.2× 101 7.5k
Paul Newbold United States 30 1.5k 2.1× 1.3k 2.8× 315 0.8× 141 0.5× 203 0.8× 88 4.4k
Eric C. Polley United States 30 369 0.5× 552 1.1× 674 1.6× 533 2.0× 626 2.5× 113 6.6k
William Peterson United States 42 429 0.6× 439 0.9× 438 1.1× 98 0.4× 365 1.4× 252 7.7k
Linda K. Green United States 40 1.2k 1.6× 1.8k 3.7× 192 0.5× 86 0.3× 463 1.8× 173 6.1k
Inke R. König Germany 49 695 1.0× 954 2.0× 144 0.3× 341 1.2× 1.5k 5.8× 261 9.4k
Duncan C. Thomas United States 56 764 1.0× 1.2k 2.4× 99 0.2× 1.3k 4.6× 619 2.4× 232 14.1k

Countries citing papers authored by Farid Kianifard

Since Specialization
Citations

This map shows the geographic impact of Farid Kianifard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Farid Kianifard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Farid Kianifard more than expected).

Fields of papers citing papers by Farid Kianifard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Farid Kianifard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Farid Kianifard. The network helps show where Farid Kianifard may publish in the future.

Co-authorship network of co-authors of Farid Kianifard

This figure shows the co-authorship network connecting the top 25 collaborators of Farid Kianifard. A scholar is included among the top collaborators of Farid Kianifard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Farid Kianifard. Farid Kianifard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Blauvelt, Andrew, David M. Pariser, Stephen K. Tyring, et al.. (2023). Psoriasis improvements and inflammatory biomarker normalization with secukinumab: the randomized ObePso-S study. Journal of Dermatological Science. 109(1). 12–21. 11 indexed citations
2.
Nguyen, Tien N., Melvin Churchill, Robert M. Levin, et al.. (2022). Secukinumab in United States Biologic-Naïve Patients With Psoriatic Arthritis: Results From the Randomized, Placebo-Controlled CHOICE Study. The Journal of Rheumatology. 49(8). 894–902. 11 indexed citations
3.
Haselkorn, Tmirah, David R. Mink, Farid Kianifard, et al.. (2021). Predominance of Atopic Asthma in Patients with Severe or Difficult-to-Treat Asthma in the TENOR-II cohort. Annals of Allergy Asthma & Immunology. 127(5). 593–595. 1 indexed citations
4.
Haselkorn, Tmirah, Stanley J. Szefler, Bradley E. Chipps, et al.. (2020). Disease Burden and Long-Term Risk of Persistent Very Poorly Controlled Asthma: TENOR II. The Journal of Allergy and Clinical Immunology In Practice. 8(7). 2243–2253. 15 indexed citations
5.
Krueger, James G., David M. Pariser, Elisa Muscianisi, et al.. (2020). 15354 Response to treatment with secukinumab in obese patients with moderate to severe psoriasis. Journal of the American Academy of Dermatology. 83(6). AB38–AB38. 6 indexed citations
6.
Busse, William W., Marc Humbert, Tmirah Haselkorn, et al.. (2019). Effect of omalizumab on lung function and eosinophil levels in adolescents with moderate-to-severe allergic asthma. Annals of Allergy Asthma & Immunology. 124(2). 190–196. 34 indexed citations
7.
Skoner, David P., Stanley Goldstein, Farid Kianifard, & Benjamin Ortiz. (2018). Clinical Characteristics of Adolescent and Adult Patients with Refractory Chronic Idiopathic Urticaria (ciu) in Three Phase Iii Studies with Omalizumab. PEDIATRICS. 141(1_MeetingAbstract). 261–261. 1 indexed citations
8.
Bagel, Jerry, Kristina Callis Duffin, Angela Moore, et al.. (2017). The effect of secukinumab on moderate-to-severe scalp psoriasis: Results of a 24-week, randomized, double-blind, placebo-controlled phase 3b study. Journal of the American Academy of Dermatology. 77(4). 667–674. 85 indexed citations
9.
Weiden, Peter J., Leslie Citrome, Gus Alva, et al.. (2014). A trial evaluating gradual- or immediate-switch strategies from risperidone, olanzapine, or aripiprazole to iloperidone in patients with schizophrenia. Schizophrenia Research. 153(1-3). 160–168. 16 indexed citations
10.
Siler, Thomas M., Craig LaForce, Farid Kianifard, Selwyn Spangenthal, & James Williams. (2014). Once-daily indacaterol 75 µg in moderate- to-severe COPD: results of a Phase IV study assessing time until patients’ perceived onset of effect. International Journal of COPD. 9. 919–919.
11.
12.
13.
Jennings, Maureen, Richard Pollak, Lawrence B. Harkless, Farid Kianifard, & Amir Tavakkol. (2006). Treatment of Toenail Onychomycosis with Oral Terbinafine Plus Aggressive Debridement. Journal of the American Podiatric Medical Association. 96(6). 465–473. 30 indexed citations
14.
Massanari, Marc, Robert Maykut, Robert K. Zeldin, Farid Kianifard, & Gregory P. Geba. (2006). ADDITION OF OMALIZUMAB IMPROVES LUNG FUNCTION AND TREATMENT EFFECTIVENESS IN PATIENTS WITH MODERATE-SEVERE PERSISTENT ALLERGIC ASTHMA INADEQUATELY CONTROLLED WITH INHALED STEROIDS AND LONG-ACTING BETA-AGONISTS. CHEST Journal. 130(4). 109S–109S. 2 indexed citations
15.
Maykut, Robert, Marc Massanari, Farid Kianifard, et al.. (2005). OMALIZUMAB IMPROVES SYMPTOMS AND REDUCES RESCUE BETA-AGONIST USE IN OLDER PATIENTS WITH UNCONTROLLED ASTHMA. CHEST Journal. 128(4). 243S–243S. 1 indexed citations
16.
Kianifard, Farid & William H. Swallow. (1996). A Review of the Development and Application of Recursive Residuals in Linear Models. Journal of the American Statistical Association. 91(433). 391–400. 41 indexed citations
17.
Cheung, Wing K., et al.. (1995). Intra- and Inter-Subject Variabilities of CGP 33101 after Replicate Single Oral Doses of Two 200-mg Tablets and 400-mg Suspension. Pharmaceutical Research. 12(12). 1878–1882. 19 indexed citations
18.
Kianifard, Farid. (1993). Applied Multivariate Data Analysis, Volume II: Categorical and Multivariate Methods. Technometrics. 35(3). 326–327. 44 indexed citations
19.
Kianifard, Farid. (1992). Applied Multivariate Data Analysis, Volume I: Regression and Experimental Design. Technometrics. 34(4). 490–491. 64 indexed citations
20.
Kianifard, Farid, et al.. (1992). Preparing High School Mathematics Teachers to Teach Statistics. The American Statistician. 46(4). 290–295. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Roger D. Peng Breakdown of academic impact, for papers by Werner Vach Breakdown of academic impact, for papers by Virginia A. Clark Breakdown of academic impact, for papers by Alan B. Forsythe Breakdown of academic impact, for papers by Paul Newbold Breakdown of academic impact, for papers by Eric C. Polley Breakdown of academic impact, for papers by William Peterson Breakdown of academic impact, for papers by Linda K. Green Breakdown of academic impact, for papers by Inke R. König Breakdown of academic impact, for papers by Duncan C. Thomas
Rankless by CCL
2026